Director buying, while welcome, not always the best buy signal. Plenty of research out about this. Nevertheless I do think we have seen the bottom and topped up at 1.38 last week. Its consolidated well over the last 7 days.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor